A carregar...
Type III TGF-β Receptor Down-Regulation Promoted Tumor Progression via Complement Component C5a Induction in Hepatocellular Carcinoma
SIMPLE SUMMARY: The clinical implications of TGFβR3 downregulation are currently unknown in hepatocellular carcinoma (HCC). Clinically, we identified that HCC patients with low expression levels of tumoral TGFβR3 exhibited significantly late tumor stages and shortened survival outcomes. Moreover, HC...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8037431/ https://ncbi.nlm.nih.gov/pubmed/33805946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071503 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|